{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:38:37Z","timestamp":1791319117495,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018504","name":"Nipro Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018504","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funding for education and research at Sapporo Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intravenous infusion of stem cells is a minimally invasive cellular delivery method, though a few have been reported in a critical limb-threatening ischemia (CLTI) animal model or patients. In the present study, we hypothesized that intravenous infusion of bone-marrow derived mesenchymal stem cells (MSCs) improves tissue perfusion in a rat hindlimb ischemia model. Hindlimb ischemia was generated in Sprague\u2013Dawley rats by femoral artery removal, then seven days after ischemic induction intravenous infusion of 1\u2009\u00d7\u200910<jats:sup>6<\/jats:sup>MSCs (cell group) or vehicle (control group) was performed. As compared with the control, tissue perfusion was significantly increased in the cell group. Histological findings showed that capillary density was significantly increased in the cell group, with infused green fluorescent protein (GFP)-MSCs distributed in the ischemic limb. Furthermore, gene expression of vascular endothelial growth factor (VEGF) was significantly increased in ischemic hindlimb muscle tissues of rats treated with MSC infusion. In conclusion, intravenous infusion of bone-marrow derived MSCs improved tissue perfusion in ischemic hindlimbs through angiogenesis, suggesting that intravenous infusion of MSCs was a promising cell delivery method for treatment of CLTI.<\/jats:p>","DOI":"10.1038\/s41598-022-18485-1","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T13:06:46Z","timestamp":1665407206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intravenous infusion of bone marrow-derived mesenchymal stem cells improves tissue perfusion in a rat hindlimb ischemia model"],"prefix":"10.1038","volume":"12","author":[{"given":"Shusaku","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akima","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Honmou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"Suppl","key":"18485_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren, L. et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45(Suppl), 5\u201367 (2007).","journal-title":"J. Vasc. Surg."},{"key":"18485_CR2","first-page":"142","volume":"12","author":"J Dormandy","year":"1999","unstructured":"Dormandy, J., Heeck, L. & Vig, S. The fate of patients with critical leg ischemia. Semin. Vasc. Surg. 12, 142\u2013147 (1999).","journal-title":"Semin. Vasc. Surg."},{"issue":"12","key":"18485_CR3","doi-asserted-by":"publisher","first-page":"e005531","DOI":"10.1161\/CIRCINTERVENTIONS.117.005531","volume":"10","author":"O Iida","year":"2017","unstructured":"Iida, O. et al. Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: The SPINACH Study (surgical reconstruction versus peripheral intervention in patients with critical limb ischemia). Circ Cardiovasc Interv. 10(12), e005531 (2017).","journal-title":"Circ Cardiovasc Interv."},{"key":"18485_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jvs.2010.08.060","volume":"53","author":"H Lawall","year":"2011","unstructured":"Lawall, H., Bramlage, P. & Amann, B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J. Vasc. Surg. 53, 445\u2013453 (2011).","journal-title":"J. Vasc. Surg."},{"key":"18485_CR5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.115.303565","volume":"116","author":"JP Cooke","year":"2015","unstructured":"Cooke, J. P. & Losordo, D. W. Modulating the vascular response to limb ischemia: Angiogenic and cell therapies. Circ. Res. 116, 1561\u20131578 (2015).","journal-title":"Circ. Res."},{"key":"18485_CR6","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/j.wneu.2021.02.056","volume":"149","author":"R Kiyose","year":"2021","unstructured":"Kiyose, R. et al. Intravenous infusion of mesenchymal stem cells enhances therapeutic efficacy of reperfusion therapy in cerebral ischemia. World Neurosurg. 149, e160\u2013e169 (2021).","journal-title":"World Neurosurg."},{"key":"18485_CR7","first-page":"1","volume":"1","author":"T Namioka","year":"2018","unstructured":"Namioka, T. et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction. J. Neurosurg. 1, 1\u20138 (2018).","journal-title":"J. Neurosurg."},{"key":"18485_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3171\/2016.8.JNS16240","volume":"127","author":"M Nakazaki","year":"2017","unstructured":"Nakazaki, M. et al. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats. J. Neurosurg. 127, 917\u2013926 (2017).","journal-title":"J. Neurosurg."},{"key":"18485_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awr063","volume":"134","author":"O Honmou","year":"2011","unstructured":"Honmou, O. et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134, 1790\u20131807 (2011).","journal-title":"Brain"},{"key":"18485_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.jcbfm.9600527","volume":"28","author":"T Onda","year":"2008","unstructured":"Onda, T. et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood Flow Metab. 28, 329\u2013340 (2008).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"18485_CR11","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/TP.0b013e3181a28533","volume":"15","author":"V Sordi","year":"2009","unstructured":"Sordi, V. Mesenchymal stem cell homing capacity. Transplantation 15, S42-45 (2009).","journal-title":"Transplantation"},{"key":"18485_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/STROKEAHA.117.018290","volume":"49","author":"LR Wechsler","year":"2018","unstructured":"Wechsler, L. R., Bates, D., Stroemer, P., Andrews-Zwilling, Y. S. & Aizman, I. Cell therapy for chronic stroke. Stroke 49, 1066\u20131074 (2018).","journal-title":"Stroke"},{"key":"18485_CR13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"27","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci, J. et al. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD Trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ. Res. 27, 1192\u20131204 (2017).","journal-title":"Circ. Res."},{"key":"18485_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nm1075","volume":"10","author":"DJ Ceradini","year":"2004","unstructured":"Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858\u2013864 (2004).","journal-title":"Nat. Med."},{"key":"18485_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230392","volume":"10","author":"T Goto","year":"2020","unstructured":"Goto, T. et al. High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFR\u03b1-positive bone marrow cells. PLoS ONE 10, e0230392 (2020).","journal-title":"PLoS ONE"},{"key":"18485_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"2","author":"RH Lee","year":"2009","unstructured":"Lee, R. H. et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2, 54\u201363 (2009).","journal-title":"Cell Stem Cell"},{"key":"18485_CR17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","volume":"12","author":"D Luger","year":"2017","unstructured":"Luger, D. et al. Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy. Circ. Res. 12, 1598\u20131613 (2017).","journal-title":"Circ. Res."},{"key":"18485_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/evj.12063","volume":"45","author":"A Sole","year":"2013","unstructured":"Sole, A. et al. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb. Equine Vet. J. 45, 726\u2013731 (2013).","journal-title":"Equine Vet. J."},{"key":"18485_CR19","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/01.CIR.0000093398.16124.29","volume":"108","author":"S Rajagopalan","year":"2003","unstructured":"Rajagopalan, S. et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, con- trolled study of adenoviral delivery of vascular endothelial growth fac- tor 121 in patients with disabling intermittent claudication. Circulation 108, 1933\u20131938 (2003).","journal-title":"Circulation"},{"key":"18485_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/mthe.2002.0638","volume":"6","author":"K M\u00e4kinen","year":"2002","unstructured":"M\u00e4kinen, K. et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: A randomized, placebo-controlled, double-blinded phase II study. Mol. Ther. 6, 127\u2013133 (2002).","journal-title":"Mol. Ther."},{"key":"18485_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/hum.2006.17.683","volume":"17","author":"YH Kusumanto","year":"2006","unstructured":"Kusumanto, Y. H. et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: A double-blind randomized trial. Hum. Gene Ther. 17, 683\u2013691 (2006).","journal-title":"Hum. Gene Ther."},{"key":"18485_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"P Carmeliet","year":"2001","unstructured":"Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575\u2013583 (2001).","journal-title":"Nat. Med."},{"key":"18485_CR23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nm884","volume":"9","author":"M Autiero","year":"2003","unstructured":"Autiero, M. et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9, 936\u2013943 (2003).","journal-title":"Nat. Med."},{"key":"18485_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","volume":"7","author":"F Pipp","year":"2003","unstructured":"Pipp, F. et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: Evidence for a monocyte-mediated mechanism. Circ. Res. 7, 378\u2013385 (2003).","journal-title":"Circ. Res."},{"key":"18485_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147040","author":"N Yasuda","year":"2020","unstructured":"Yasuda, N. et al. Intravenous delivery of mesenchymal stem cells protects both white and gray matter in spinal cord ischemia. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2020.147040 (2020).","journal-title":"Brain Res."},{"key":"18485_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1089\/neu.2006.0161","volume":"24","author":"R Ukai","year":"2007","unstructured":"Ukai, R. et al. Mesenchymal stem cells derived from peripheral blood protects against ischemia. J. Neurotrauma 24, 508\u2013520 (2007).","journal-title":"J. Neurotrauma"},{"key":"18485_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainres.2006.09.044","volume":"1123","author":"S Kim","year":"2006","unstructured":"Kim, S. et al. Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res. 1123, 27\u201333 (2006).","journal-title":"Brain Res."},{"key":"18485_CR28","first-page":"1","volume":"1","author":"M Takemura","year":"2021","unstructured":"Takemura, M. et al. Repeated intravenous infusion of mesenchymal stem cells for enhanced functional recovery in a rat model of chronic cerebral ischemia. J. Neurosurg. 1, 1\u201310 (2021).","journal-title":"J. Neurosurg."},{"key":"18485_CR29","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/s41598-021-82284-3","volume":"28","author":"S Maeda","year":"2021","unstructured":"Maeda, S. et al. Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model. Sci. Rep. 28, 2543 (2021).","journal-title":"Sci. Rep."},{"key":"18485_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/ATVBAHA.117.309524","volume":"38","author":"P Robinet","year":"2018","unstructured":"Robinet, P. et al. Consideration of sex differences in design and reporting of experimental arterial pathology studies-statement from ATVB council. Arterioscler. Thromb. Vasc. Biol. 38, 292\u2013303 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"18485_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eplepsyres.2018.02.008","volume":"141","author":"S Fukumura","year":"2018","unstructured":"Fukumura, S. et al. Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus. Epilepsy Res. 141, 56\u201363 (2018).","journal-title":"Epilepsy Res."},{"key":"18485_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147296","volume":"1757","author":"H Magota","year":"2021","unstructured":"Magota, H. et al. Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model. Brain Res. 1757, 147296 (2021).","journal-title":"Brain Res."},{"key":"18485_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.esxm.2017.10.005","volume":"6","author":"Y Matsuda","year":"2018","unstructured":"Matsuda, Y. et al. Intravenous infusion of bone marrow-derived mesenchymal stem cells reduces erectile dysfunction following cavernous nerve injury in rats. Sexual Med. 6, 49\u201357 (2018).","journal-title":"Sexual Med."},{"key":"18485_CR34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PRS.0000000000008327","volume":"148","author":"T Nakagawa","year":"2021","unstructured":"Nakagawa, T. et al. Intravenous infusion of mesenchymal stem cells promotes the survival of random pattern flaps in rats. Plast. Reconstr. Surg. 148, 799\u2013807 (2021).","journal-title":"Plast. Reconstr. Surg."},{"key":"18485_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.neuroscience.2019.04.018","volume":"408","author":"M Nakazaki","year":"2019","unstructured":"Nakazaki, M. et al. Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model. Neuroscience 408, 361\u2013377 (2019).","journal-title":"Neuroscience"},{"key":"18485_CR36","first-page":"1","volume":"131","author":"A Namioka","year":"2018","unstructured":"Namioka, A. et al. Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat. J. Neurosurg. 131, 1\u20139 (2018).","journal-title":"J. Neurosurg."},{"key":"18485_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/neu.2018.5793","volume":"36","author":"T Oshigiri","year":"2019","unstructured":"Oshigiri, T. et al. Intravenous infusion of mesenchymal stem cells alters motor cortex gene expression in a rat model of acute spinal cord injury. J. Neurotrauma 36, 411\u2013420 (2019).","journal-title":"J. Neurotrauma"},{"key":"18485_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3171\/2018.5.PEDS1845","volume":"22","author":"T Sakai","year":"2018","unstructured":"Sakai, T. et al. Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia. J. Neurosurg. Pediatr. 22, 513\u2013522 (2018).","journal-title":"J. Neurosurg. Pediatr."},{"key":"18485_CR39","doi-asserted-by":"publisher","first-page":"14932","DOI":"10.1523\/JNEUROSCI.2769-09.2009","volume":"29","author":"M Sasaki","year":"2009","unstructured":"Sasaki, M. et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J. Neurosci. 29, 14932\u201314941 (2009).","journal-title":"J. Neurosci."},{"key":"18485_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12894-021-00923-3","volume":"21","author":"H Tabata","year":"2021","unstructured":"Tabata, H. et al. Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis\/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in rat. BMC Urol. 21, 156 (2021).","journal-title":"BMC Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18485-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T17:53:48Z","timestamp":1701194028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18485-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18485"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18485-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16986"}}